RecruitingNot ApplicableNCT06404632

A Group Intervention for Promoting Health-related Habits (LEV-G)

A Group Intervention for Promoting Health-related Habits in Individuals With Disabilities (LEV-G)


Sponsor

Region Stockholm

Enrollment

30 participants

Start Date

Apr 12, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Health-related habits influences mental and physical health. Still, treatment of health-related habits, which can help to remedy health problems, is often not done at all or very superficially. Multiple guidelines emphasize the importance of prioritizing health-related habits, but there is a lack of implemented models. To solve this, the investigators have developed a transdiagnostic, interprofessional material intended for several care settings. The Lev-g intervention is intended for groups. There is also an individual version of Lev that has its on registration in Clinical Trails.


Eligibility

Min Age: 15 YearsMax Age: 80 Years

Inclusion Criteria1

  • both adults with and without disabilities recruited from different healthcare contexts.

Exclusion Criteria3

  • Intellectual disability of the degree where the participant is not able to follow the protocol in Lev.
  • Insufficient command of the Swedish language/ unable to understand the content.
  • Severe psychiatric comorbidity that makes participation difficult (e.g. severe depression, severe suicidality, severe anxiety, ongoing psychosis, manic episode), other circumstances that could make participation hard (e.g. homelessness).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALLev-g

Lev-g includes three sessions + a booster session using psychoeducation, motivational interviewing, and applied behavioral analyses. Lev-g is done in groups to enable support and tips from others.


Locations(1)

Region Stockholm

Stockholm, Stockholm, Sweden, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06404632


Related Trials